See how executives trade. Alexion Pharmaceuticals Inc. secarticle SEC filings breakout by MarketWatch. View the ALXN U.S. Securities and Exchange Commission reporting information. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Alexion Pharmaceuticals, Inc.. SEC filings and transcripts for Alexion Pharmaceuticals Inc., including financials, news, proxies, indentures, prospectuses, and credit agreements alxn / alexion pharmaceuticals, inc. / state street corp - alexion pharmaceuticals, inc. passive investment. Alexion Pharmaceuticals Inc. 8k SEC filings breakout by MarketWatch. The Investor Relations website contains information about Alexion Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts. Notable SEC filings of Alexion Pharmaceuticals Inc. All filings Last yearly filing Filter. In connection with the proposed acquisition of Achillion by Alexion, Achillion intends to file with the SEC a proxy statement, as well as other relevant … View the ALXN report for changes in beneficial ownership of more than 5% by date. Note to Investors and Security Holders . Search. This page shows recent SEC filings related to Alexion Pharmaceuticals, Inc. For financial reporting, their fiscal year ends on December 31st. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. And then, after the market close, we found out in an SEC filing that the mystery buyer was Alexion. SEC Filings for Alexion Pharmaceuticals Inc. (ALXN) 116.33 0.34 (+0.29%) Volume: 1.61m 4:00 PM EDT Jun 10, 2020 Filing Type: : 133648318 | State of Incorp. 10-K 8 Feb 2021: Yearly report 8-K 4 Feb 2021: Results of Operations and Financial Condition; Financial Statements and Exhibits 8-K 12 Jan 2021: Filter, compare, and track stocks. Analyze up to 10 years of full 10K Annual Reports and Quarterly 10Q SEC filings for Alexion Pharmaceuticals, Inc. (ALXN) using our online tools. ALEXION PHARMACEUTICALS, INC. (Filed by) CIK: 0000899866 (see all company filings) IRS No. Information about the directors and executive officers of Alexion and their ownership of Alexion shares is set forth in the definitive proxy statement for Alexion’s 2020 special meeting of shareholders, as previously filed with the SEC on March 26, 2020. Alexion Pharmaceuticals, Inc. - ‘8-K’ for 1/12/21 Current Report - Seq. SEC Filings Group 3,4,5 Annual Filings Current Reports Mergers & Acquisitions Other Proxy Filings Quarterly Filings Registration Statements Filing year - Any - 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 View the ALXN U.S. Securities and Exchange Commission reporting information. Search SEC filings. Annotate, download XLSX & look up similar tables. Related SEC Filings. Search. This communication does not constitute a solicitation of any vote or approval. :DE | Fiscal Year End: 1231 Type: 425 SIC: 2834 Pharmaceutical Preparations Office of Life Sciences 2 ALXN / Alexion Pharmaceuticals, Inc. / FMR LLC / Fidelity Passive Investment. Alexion is a global biopharmaceutical company focused on developing life-changing therapies for people living with rare disorders. Notable SEC filings of Alexion Pharmaceuticals Inc. All filings Last yearly filing Filter. ALEXION PHARMACEUTICALS, INC. (Filed by) CIK: 0000899866 (see all company filings) IRS No. Alexion Pharmaceuticals Inc. SEC filings breakout by MarketWatch. Insiders trading. Free copies of these documents may be obtained as described in the paragraphs above. The order finds that, from 2010 to 2015, Alexion Turkey paid Turkish government officials to improperly influence them to approve patient prescriptions and provide other favorable regulatory treatment for Soliris. Stock screener. 1 - Accession Number 0001140361-21-000872 - Filing - SEC Alexion Pharmaceuticals Inc. 13D SEC filings breakout by MarketWatch. :DE | Fiscal Year End: 1231 Type: 425 SIC: 2834 Pharmaceutical Preparations Office of Life Sciences According to the SEC’s order, two Alexion subsidiaries made payments to foreign government officials to secure favorable treatment for Alexion’s primary drug, Soliris. Alexion Pharmaceuticals SEC Filings & 10K Form Most-Downgraded Stocks $155.69-6.06 (-3.75 %) (As of 01/27 ... SEC filings and insider transactions for your stocks. : 133648318 | State of Incorp. View the ALXN report for unscheduled material events or corporate changes by date. Find the latest SEC Filings data for Alexion Pharmaceuticals, Inc. Common Stock (ALXN) at Nasdaq.com. 3 Alexion Pharmaceuticals, Inc. SEC Filing - Amended Annual Report (10-K/A) February 16, 2021 SEC Filings Tue, Feb. 16 PhaseBio shares spike 22% in afternoon trading 2019-02-14 sec.gov - 1 - SCHEDULE 13G Amendment No. After the registration statement is declared effective by the SEC, Alexion intends to file with the SEC and mail to its ... in each case as amended by any subsequent filings made with the SEC. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. Alexion Pharmaceuticals, Inc is primarely in the business of pharmaceutical preparations. Latest SEC filings for Alexion Pharmaceuticals, Inc. (ALXN). Alexion Pharmaceuticals, Inc. - SEC Filings - Registrant - CIK 899866 - SEC SEC Filings Group 3,4,5 Annual Filings Current Reports Mergers & Acquisitions Other Proxy Filings Quarterly Filings Registration Statements Filing year - Any - 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Mörderische Spiele Staffel 2 Stream, Herzlichen Glückwunsch Zum Geburtstag Auf Schwedisch, Historischen Dareios Den Großen, Collant Thermo Polaire Dim, Elebrato Ellipta 92/55/22 Wirkstoff, Soraya Naturalnie Krem Skład, Fisher Price Tournament Table For Sale,
Neue Kommentare